|
Video: What is a Stock Split?
|
|
Harvard Bioscience develops, manufactures and sells technologies, products and services that enable fundamental develops in life science applications. Co.'s product families are cellular and molecular technology (CMT) and Preclinical. Co.'s CMT product family includes products supporting research related to molecular, cellular organ and organoid technologies, with additional application in the field of bio-production of pharmaceuticals and therapeutics. Co.'s Preclinical product family includes business lines that support the preclinical research and testing phase for drug development, and in particular testing related to data collection and analysis for safety and regulatory compliance. According to our HBIO split history records, Harvard Bioscience has had 1 split. | |
|
Harvard Bioscience (HBIO) has 1 split in our HBIO split history database. The split for HBIO took place on November 04, 2013. This was a 1319 for 1000 split, meaning for each 1000 shares of HBIO owned pre-split, the shareholder now owned 1319 shares. For example, a 1000 share position pre-split, became a 1319 share position following the split.
When a company such as Harvard Bioscience splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.
Looking at the HBIO split history from start to finish, an original position size of 1000 shares would have turned into 1319 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Harvard Bioscience shares, starting with a $10,000 purchase of HBIO, presented on a split-history-adjusted basis factoring in the complete HBIO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/24/2014 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$4.46 |
|
End price/share: |
$3.70 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-17.04% |
|
Average Annual Total Return: |
-1.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,296.23 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
11/04/2013 | 1319 for 1000 |
|
|